Clinical characteristics of children with COVID-19: a rapid review and meta-analysis

doi:10.21037/atm-20-3302

. 2020 May;8(10):620.

doi: 10.21037/atm-20-3302.

Clinical characteristics of children with COVID-19: a rapid review and meta-analysis

Zijun Wang¹, Qi Zhou², Chenglin Wang^{3

4

5}, Qianling Shi², Shuya Lu^{6

7}, Yanfang Ma¹, Xufei Luo⁸, Yangqin Xun¹, Weiguo Li^{3

4

5}, Muna Baskota^{3

4

5}, Yinmei Yang^{3

4

5}, Hui Zhai^{3

4

5}, Toshio Fukuoka^{9

10}, Hyeong Sik Ahn^{11

12}, Myeong Soo Lee^{13

14}, Zhengxiu Luo^{3

4

5}, Enmei Liu^{3

4

5}, Yaolong Chen^{1

15

16

17}; COVID-19 Evidence and Recommendations Working Group

Affiliations

¹ Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
² The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
³ Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
⁴ National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
⁵ Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.
⁶ Department of Pediatric, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 611731, China.
⁷ Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu 610072, China.
⁸ School of Public Health, Lanzhou University, Lanzhou 730000, China.
⁹ Emergency and Critical Care Center, Department of General Medicine, Department of Research and Medical Education, Kurashiki Central Hospital, Kurashiki, Japan.
¹⁰ Advisory Committee in Cochrane Japan, Tokyo, Japan.
¹¹ Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea.
¹² Korea Cochrane Center, Seoul, Korea.
¹³ Korea Institute of Oriental Medicine, Daejeon, Korea.
¹⁴ University of Science and Technology, Daejeon, Korea.
¹⁵ Lanzhou University, an Affiliate of the Cochrane China Network, Lanzhou 730000, China.
¹⁶ Chinese GRADE Center, Lanzhou 730000, China.
¹⁷ Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou University, Lanzhou 730000, China.

PMID: 32566557
PMCID: PMC7290619
DOI: 10.21037/atm-20-3302

Clinical characteristics of children with COVID-19: a rapid review and meta-analysis

Zijun Wang et al. Ann Transl Med. 2020 May.

. 2020 May;8(10):620.

doi: 10.21037/atm-20-3302.

Authors

Affiliations

¹ Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
² The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
³ Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
⁴ National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
⁵ Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.
⁶ Department of Pediatric, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 611731, China.
⁷ Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu 610072, China.
⁸ School of Public Health, Lanzhou University, Lanzhou 730000, China.
⁹ Emergency and Critical Care Center, Department of General Medicine, Department of Research and Medical Education, Kurashiki Central Hospital, Kurashiki, Japan.
¹⁰ Advisory Committee in Cochrane Japan, Tokyo, Japan.
¹¹ Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea.
¹² Korea Cochrane Center, Seoul, Korea.
¹³ Korea Institute of Oriental Medicine, Daejeon, Korea.
¹⁴ University of Science and Technology, Daejeon, Korea.
¹⁵ Lanzhou University, an Affiliate of the Cochrane China Network, Lanzhou 730000, China.
¹⁶ Chinese GRADE Center, Lanzhou 730000, China.
¹⁷ Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou University, Lanzhou 730000, China.

PMID: 32566557
PMCID: PMC7290619
DOI: 10.21037/atm-20-3302

Abstract

Background: Most guidelines on COVID-19 published so far include recommendations for patients regardless of age. Clinicians need a more accurate understanding of the clinical characteristics of children with COVID-19.

Methods: We searched studies reporting clinical characteristics in children with COVID-19 published until March 31, 2020. We screened the literature, extracted the data and evaluated the risk of bias and quality of evidence of the included studies. We combined some of the outcomes (symptoms) in a single-arm meta-analysis using a random-effects model.

Results: Our search retrieved 49 studies, including 25 case reports, 23 case series and one cohort study, with a total of 1,667 patients. Our meta-analysis showed that most children with COVID-19 have mild symptoms. Eighty-three percent of the children were within family clusters of cases, and 19% had no symptoms. At least 7% with digestive symptoms. The main symptoms of children were fever [48%, 95% confidence interval (CI): 39%, 56%] and cough (39%, 95% CI: 30%, 48%). The lymphocyte count was below normal level in only 15% (95% CI: 8%, 22%) of children which is different from adult patients. 66% (95% CI: 55%, 77%) of children had abnormal findings in CT imaging.

Conclusions: Most children with COVID-19 have only mild symptoms, and many children are asymptomatic. Fever and cough are the most common symptoms in children. Vomiting and diarrhea were not common in children. The lymphocyte count is usually within the normal range in children.

Keywords: COVID-19; Children; clinical characteristics; meta-analysis; rapid review.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3302). MSL serves as the unpaid editorial board member of Annals of Translational Medicine from Nov 2019 to Oct 2021. The other authors have no conflicts of interest to declare.

Figures

See this image and copyright information in PMC

Cited by

Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients.
Hasan MZ, Islam S, Matsumoto K, Kawai T. Hasan MZ, et al. Comput Biol Med. 2021 Oct;137:104792. doi: 10.1016/j.compbiomed.2021.104792. Epub 2021 Aug 27. Comput Biol Med. 2021. PMID: 34478921 Free PMC article.
Is liver involvement overestimated in COVID-19 patients? A meta-analysis.
Li G, Yang Y, Gao D, Xu Y, Gu J, Liu P. Li G, et al. Int J Med Sci. 2021 Jan 18;18(5):1285-1296. doi: 10.7150/ijms.51174. eCollection 2021. Int J Med Sci. 2021. PMID: 33526990 Free PMC article.
COVID-19 in Portugal: a retrospective review of paediatric cases, hospital and PICU admissions in the first pandemic year.
Elias C, Feteira-Santos R, Camarinha C, de Araújo Nobre M, Costa AS, Bacelar-Nicolau L, Furtado C, Nogueira PJ. Elias C, et al. BMJ Paediatr Open. 2022 Aug;6(1):e001499. doi: 10.1136/bmjpo-2022-001499. BMJ Paediatr Open. 2022. PMID: 36053592 Free PMC article.
Repurposing of Rutan showed effective treatment for COVID-19 disease.
Salikhov SI, Abdurakhmonov IY, Oshchepkova YI, Ziyavitdinov JF, Berdiev NS, Aisa HA, Shen J, Xu Y, Xu HE, Jiang X, Zhang L, Vypova NL, Allaberganov DS, Tagayalieva NA, Musabaev EI, Ibadova GA, Rajabov IB, Lokteva LM. Salikhov SI, et al. Front Med (Lausanne). 2023 Nov 29;10:1310129. doi: 10.3389/fmed.2023.1310129. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38093975 Free PMC article.
Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
Ghayda RA, Lee J, Lee JY, Kim DK, Lee KH, Hong SH, Han YJ, Kim JS, Yang JW, Kronbichler A, Smith L, Koyanagi A, Jacob L, Shin JI. Ghayda RA, et al. Int J Environ Res Public Health. 2020 Jul 13;17(14):5026. doi: 10.3390/ijerph17145026. Int J Environ Res Public Health. 2020. PMID: 32668763 Free PMC article.

See all "Cited by" articles

References

1. World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. 2020. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at...
1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. 10.1056/NEJMoa2001017 - DOI - PMC - PubMed
1. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74. 10.1016/S0140-6736(20)30251-8 - DOI - PMC - PubMed
1. Li Q, Guan X, Wu P, et al. Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-207. 10.1056/NEJMoa2001316 - DOI - PMC - PubMed
1. Yu P, Zhu J, Zhang Z, et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis 2020. doi: .10.1093/infdis/jiaa077 - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov

[1] World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. 2020. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at...

[2] World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. 2020. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at...

[3] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. 10.1056/NEJMoa2001017 - DOI - PMC - PubMed

[4] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. 10.1056/NEJMoa2001017 - DOI - PMC - PubMed

[5] Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74. 10.1016/S0140-6736(20)30251-8 - DOI - PMC - PubMed

[6] Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74. 10.1016/S0140-6736(20)30251-8 - DOI - PMC - PubMed

[7] Li Q, Guan X, Wu P, et al. Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-207. 10.1056/NEJMoa2001316 - DOI - PMC - PubMed

[8] Li Q, Guan X, Wu P, et al. Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-207. 10.1056/NEJMoa2001316 - DOI - PMC - PubMed

[9] Yu P, Zhu J, Zhang Z, et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis 2020. doi: .10.1093/infdis/jiaa077 - DOI - PMC - PubMed

[10] Yu P, Zhu J, Zhang Z, et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis 2020. doi: .10.1093/infdis/jiaa077 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Clinical characteristics of children with COVID-19: a rapid review and meta-analysis

Affiliations

Clinical characteristics of children with COVID-19: a rapid review and meta-analysis

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Medical